Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Fatigue in Parkinson's Disease: Prevalence and Associated Factors

Identifieur interne : 000825 ( PascalFrancis/Corpus ); précédent : 000824; suivant : 000826

Fatigue in Parkinson's Disease: Prevalence and Associated Factors

Auteurs : Antoine G. Beiske ; Jon Havard Loge ; Marianne J. Hjermstad ; Elisabeth Svensson

Source :

RBID : Pascal:10-0491629

Descripteurs français

English descriptors

Abstract

The purpose of this study was to examine the prevalence of fatigue in Parkinson's disease (PD) patients and compare this to the general population. Factors associated with fatigue were investigated by linear regression. Fatigue was assessed by the fatigue questionnaire. The mean age of the 176 PD patients (41 % women) was 69 years (range 35-90), and the mean UPDRSIII was 22.3 (SD 11.7). Fatigue levels (means) were significantly higher in PD patients compared with the general population; however, effect sizes were moderate for women for physical and total fatigue indicating clinically significant differences here only. Only female PD patients had more chronic fatigue than the general population. Fatigue was related to characteristics of PD but also to sleep disturbance, depression, and gender. This population-based study demonstrates that fatigue is a common symptom in PD patients, but compared with the general population, clinically significant differences were only found for female PD patients.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0885-3185
A03   1    @0 Mov. disord.
A05       @2 25
A06       @2 14
A08 01  1  ENG  @1 Fatigue in Parkinson's Disease: Prevalence and Associated Factors
A11 01  1    @1 BEISKE (Antoine G.)
A11 02  1    @1 HAVARD LOGE (Jon)
A11 03  1    @1 HJERMSTAD (Marianne J.)
A11 04  1    @1 SVENSSON (Elisabeth)
A14 01      @1 Department of Neurology, Akershus University Hospital @3 NOR @Z 1 aut.
A14 02      @1 Department of Oncology, National Resource Centre for Late Effects, Oslo University Hospital Montebello @3 NOR @Z 2 aut.
A14 03      @1 Department of Behavioural Sciences in Medicine, University of Oslo @3 NOR @Z 2 aut.
A14 04      @1 Department of Oncology, Regional Centre for Excellence in Palliative Care, Oslo University Hospital @2 Ulleval @3 NOR @Z 3 aut.
A14 05      @1 Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology @3 NOR @Z 3 aut.
A14 06      @1 Department of Adult Mental Health, Division of Mental Health, Norwegian Institute of Public Health @3 NOR @Z 4 aut.
A20       @1 2456-2460
A21       @1 2010
A23 01      @0 ENG
A43 01      @1 INIST @2 20953 @5 354000192780100290
A44       @0 0000 @1 © 2010 INIST-CNRS. All rights reserved.
A45       @0 29 ref.
A47 01  1    @0 10-0491629
A60       @1 P @3 CC
A61       @0 A
A64 01  1    @0 Movement disorders
A66 01      @0 USA
C01 01    ENG  @0 The purpose of this study was to examine the prevalence of fatigue in Parkinson's disease (PD) patients and compare this to the general population. Factors associated with fatigue were investigated by linear regression. Fatigue was assessed by the fatigue questionnaire. The mean age of the 176 PD patients (41 % women) was 69 years (range 35-90), and the mean UPDRSIII was 22.3 (SD 11.7). Fatigue levels (means) were significantly higher in PD patients compared with the general population; however, effect sizes were moderate for women for physical and total fatigue indicating clinically significant differences here only. Only female PD patients had more chronic fatigue than the general population. Fatigue was related to characteristics of PD but also to sleep disturbance, depression, and gender. This population-based study demonstrates that fatigue is a common symptom in PD patients, but compared with the general population, clinically significant differences were only found for female PD patients.
C02 01  X    @0 002B17
C02 02  X    @0 002B17G
C03 01  X  FRE  @0 Maladie de Parkinson @2 NM @5 01
C03 01  X  ENG  @0 Parkinson disease @2 NM @5 01
C03 01  X  SPA  @0 Parkinson enfermedad @2 NM @5 01
C03 02  X  FRE  @0 Syndrome de fatigue chronique @2 NM @5 02
C03 02  X  ENG  @0 Chronic fatigue syndrome @2 NM @5 02
C03 02  X  SPA  @0 Fatiga crónica síndrome @2 NM @5 02
C03 03  X  FRE  @0 Pathologie du système nerveux @5 03
C03 03  X  ENG  @0 Nervous system diseases @5 03
C03 03  X  SPA  @0 Sistema nervioso patología @5 03
C03 04  X  FRE  @0 Fatigue @5 09
C03 04  X  ENG  @0 Fatigue @5 09
C03 04  X  SPA  @0 Fatiga @5 09
C03 05  X  FRE  @0 Prévalence @5 10
C03 05  X  ENG  @0 Prevalence @5 10
C03 05  X  SPA  @0 Prevalencia @5 10
C03 06  X  FRE  @0 Norvège @2 NG @5 11
C03 06  X  ENG  @0 Norway @2 NG @5 11
C03 06  X  SPA  @0 Noruega @2 NG @5 11
C07 01  X  FRE  @0 Europe @2 NG
C07 01  X  ENG  @0 Europe @2 NG
C07 01  X  SPA  @0 Europa @2 NG
C07 02  X  FRE  @0 Pathologie de l'encéphale @5 37
C07 02  X  ENG  @0 Cerebral disorder @5 37
C07 02  X  SPA  @0 Encéfalo patología @5 37
C07 03  X  FRE  @0 Syndrome extrapyramidal @5 38
C07 03  X  ENG  @0 Extrapyramidal syndrome @5 38
C07 03  X  SPA  @0 Extrapiramidal síndrome @5 38
C07 04  X  FRE  @0 Maladie dégénérative @5 39
C07 04  X  ENG  @0 Degenerative disease @5 39
C07 04  X  SPA  @0 Enfermedad degenerativa @5 39
C07 05  X  FRE  @0 Pathologie du système nerveux central @5 40
C07 05  X  ENG  @0 Central nervous system disease @5 40
C07 05  X  SPA  @0 Sistema nervosio central patología @5 40
N21       @1 326
N44 01      @1 OTO
N82       @1 OTO

Format Inist (serveur)

NO : PASCAL 10-0491629 INIST
ET : Fatigue in Parkinson's Disease: Prevalence and Associated Factors
AU : BEISKE (Antoine G.); HAVARD LOGE (Jon); HJERMSTAD (Marianne J.); SVENSSON (Elisabeth)
AF : Department of Neurology, Akershus University Hospital/Norvège (1 aut.); Department of Oncology, National Resource Centre for Late Effects, Oslo University Hospital Montebello/Norvège (2 aut.); Department of Behavioural Sciences in Medicine, University of Oslo/Norvège (2 aut.); Department of Oncology, Regional Centre for Excellence in Palliative Care, Oslo University Hospital/Ulleval/Norvège (3 aut.); Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology/Norvège (3 aut.); Department of Adult Mental Health, Division of Mental Health, Norwegian Institute of Public Health/Norvège (4 aut.)
DT : Publication en série; Courte communication, note brève; Niveau analytique
SO : Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2010; Vol. 25; No. 14; Pp. 2456-2460; Bibl. 29 ref.
LA : Anglais
EA : The purpose of this study was to examine the prevalence of fatigue in Parkinson's disease (PD) patients and compare this to the general population. Factors associated with fatigue were investigated by linear regression. Fatigue was assessed by the fatigue questionnaire. The mean age of the 176 PD patients (41 % women) was 69 years (range 35-90), and the mean UPDRSIII was 22.3 (SD 11.7). Fatigue levels (means) were significantly higher in PD patients compared with the general population; however, effect sizes were moderate for women for physical and total fatigue indicating clinically significant differences here only. Only female PD patients had more chronic fatigue than the general population. Fatigue was related to characteristics of PD but also to sleep disturbance, depression, and gender. This population-based study demonstrates that fatigue is a common symptom in PD patients, but compared with the general population, clinically significant differences were only found for female PD patients.
CC : 002B17; 002B17G
FD : Maladie de Parkinson; Syndrome de fatigue chronique; Pathologie du système nerveux; Fatigue; Prévalence; Norvège
FG : Europe; Pathologie de l'encéphale; Syndrome extrapyramidal; Maladie dégénérative; Pathologie du système nerveux central
ED : Parkinson disease; Chronic fatigue syndrome; Nervous system diseases; Fatigue; Prevalence; Norway
EG : Europe; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease
SD : Parkinson enfermedad; Fatiga crónica síndrome; Sistema nervioso patología; Fatiga; Prevalencia; Noruega
LO : INIST-20953.354000192780100290
ID : 10-0491629

Links to Exploration step

Pascal:10-0491629

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Fatigue in Parkinson's Disease: Prevalence and Associated Factors</title>
<author>
<name sortKey="Beiske, Antoine G" sort="Beiske, Antoine G" uniqKey="Beiske A" first="Antoine G." last="Beiske">Antoine G. Beiske</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Neurology, Akershus University Hospital</s1>
<s3>NOR</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Havard Loge, Jon" sort="Havard Loge, Jon" uniqKey="Havard Loge J" first="Jon" last="Havard Loge">Jon Havard Loge</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Department of Oncology, National Resource Centre for Late Effects, Oslo University Hospital Montebello</s1>
<s3>NOR</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="03">
<s1>Department of Behavioural Sciences in Medicine, University of Oslo</s1>
<s3>NOR</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Hjermstad, Marianne J" sort="Hjermstad, Marianne J" uniqKey="Hjermstad M" first="Marianne J." last="Hjermstad">Marianne J. Hjermstad</name>
<affiliation>
<inist:fA14 i1="04">
<s1>Department of Oncology, Regional Centre for Excellence in Palliative Care, Oslo University Hospital</s1>
<s2>Ulleval</s2>
<s3>NOR</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="05">
<s1>Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology</s1>
<s3>NOR</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Svensson, Elisabeth" sort="Svensson, Elisabeth" uniqKey="Svensson E" first="Elisabeth" last="Svensson">Elisabeth Svensson</name>
<affiliation>
<inist:fA14 i1="06">
<s1>Department of Adult Mental Health, Division of Mental Health, Norwegian Institute of Public Health</s1>
<s3>NOR</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">10-0491629</idno>
<date when="2010">2010</date>
<idno type="stanalyst">PASCAL 10-0491629 INIST</idno>
<idno type="RBID">Pascal:10-0491629</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000825</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Fatigue in Parkinson's Disease: Prevalence and Associated Factors</title>
<author>
<name sortKey="Beiske, Antoine G" sort="Beiske, Antoine G" uniqKey="Beiske A" first="Antoine G." last="Beiske">Antoine G. Beiske</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Neurology, Akershus University Hospital</s1>
<s3>NOR</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Havard Loge, Jon" sort="Havard Loge, Jon" uniqKey="Havard Loge J" first="Jon" last="Havard Loge">Jon Havard Loge</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Department of Oncology, National Resource Centre for Late Effects, Oslo University Hospital Montebello</s1>
<s3>NOR</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="03">
<s1>Department of Behavioural Sciences in Medicine, University of Oslo</s1>
<s3>NOR</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Hjermstad, Marianne J" sort="Hjermstad, Marianne J" uniqKey="Hjermstad M" first="Marianne J." last="Hjermstad">Marianne J. Hjermstad</name>
<affiliation>
<inist:fA14 i1="04">
<s1>Department of Oncology, Regional Centre for Excellence in Palliative Care, Oslo University Hospital</s1>
<s2>Ulleval</s2>
<s3>NOR</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="05">
<s1>Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology</s1>
<s3>NOR</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Svensson, Elisabeth" sort="Svensson, Elisabeth" uniqKey="Svensson E" first="Elisabeth" last="Svensson">Elisabeth Svensson</name>
<affiliation>
<inist:fA14 i1="06">
<s1>Department of Adult Mental Health, Division of Mental Health, Norwegian Institute of Public Health</s1>
<s3>NOR</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint>
<date when="2010">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Chronic fatigue syndrome</term>
<term>Fatigue</term>
<term>Nervous system diseases</term>
<term>Norway</term>
<term>Parkinson disease</term>
<term>Prevalence</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Maladie de Parkinson</term>
<term>Syndrome de fatigue chronique</term>
<term>Pathologie du système nerveux</term>
<term>Fatigue</term>
<term>Prévalence</term>
<term>Norvège</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The purpose of this study was to examine the prevalence of fatigue in Parkinson's disease (PD) patients and compare this to the general population. Factors associated with fatigue were investigated by linear regression. Fatigue was assessed by the fatigue questionnaire. The mean age of the 176 PD patients (41 % women) was 69 years (range 35-90), and the mean UPDRSIII was 22.3 (SD 11.7). Fatigue levels (means) were significantly higher in PD patients compared with the general population; however, effect sizes were moderate for women for physical and total fatigue indicating clinically significant differences here only. Only female PD patients had more chronic fatigue than the general population. Fatigue was related to characteristics of PD but also to sleep disturbance, depression, and gender. This population-based study demonstrates that fatigue is a common symptom in PD patients, but compared with the general population, clinically significant differences were only found for female PD patients.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0885-3185</s0>
</fA01>
<fA03 i2="1">
<s0>Mov. disord.</s0>
</fA03>
<fA05>
<s2>25</s2>
</fA05>
<fA06>
<s2>14</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Fatigue in Parkinson's Disease: Prevalence and Associated Factors</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>BEISKE (Antoine G.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>HAVARD LOGE (Jon)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>HJERMSTAD (Marianne J.)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>SVENSSON (Elisabeth)</s1>
</fA11>
<fA14 i1="01">
<s1>Department of Neurology, Akershus University Hospital</s1>
<s3>NOR</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Department of Oncology, National Resource Centre for Late Effects, Oslo University Hospital Montebello</s1>
<s3>NOR</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>Department of Behavioural Sciences in Medicine, University of Oslo</s1>
<s3>NOR</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="04">
<s1>Department of Oncology, Regional Centre for Excellence in Palliative Care, Oslo University Hospital</s1>
<s2>Ulleval</s2>
<s3>NOR</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="05">
<s1>Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology</s1>
<s3>NOR</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="06">
<s1>Department of Adult Mental Health, Division of Mental Health, Norwegian Institute of Public Health</s1>
<s3>NOR</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA20>
<s1>2456-2460</s1>
</fA20>
<fA21>
<s1>2010</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>20953</s2>
<s5>354000192780100290</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2010 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>29 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>10-0491629</s0>
</fA47>
<fA60>
<s1>P</s1>
<s3>CC</s3>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Movement disorders</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>The purpose of this study was to examine the prevalence of fatigue in Parkinson's disease (PD) patients and compare this to the general population. Factors associated with fatigue were investigated by linear regression. Fatigue was assessed by the fatigue questionnaire. The mean age of the 176 PD patients (41 % women) was 69 years (range 35-90), and the mean UPDRSIII was 22.3 (SD 11.7). Fatigue levels (means) were significantly higher in PD patients compared with the general population; however, effect sizes were moderate for women for physical and total fatigue indicating clinically significant differences here only. Only female PD patients had more chronic fatigue than the general population. Fatigue was related to characteristics of PD but also to sleep disturbance, depression, and gender. This population-based study demonstrates that fatigue is a common symptom in PD patients, but compared with the general population, clinically significant differences were only found for female PD patients.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Maladie de Parkinson</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Parkinson disease</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Parkinson enfermedad</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Syndrome de fatigue chronique</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Chronic fatigue syndrome</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Fatiga crónica síndrome</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Pathologie du système nerveux</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Fatigue</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Fatigue</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Fatiga</s0>
<s5>09</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Prévalence</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Prevalence</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Prevalencia</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Norvège</s0>
<s2>NG</s2>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Norway</s0>
<s2>NG</s2>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Noruega</s0>
<s2>NG</s2>
<s5>11</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Europe</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Europe</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Europa</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Pathologie de l'encéphale</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Cerebral disorder</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Encéfalo patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Syndrome extrapyramidal</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Extrapiramidal síndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Maladie dégénérative</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Degenerative disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Enfermedad degenerativa</s0>
<s5>39</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Pathologie du système nerveux central</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Central nervous system disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Sistema nervosio central patología</s0>
<s5>40</s5>
</fC07>
<fN21>
<s1>326</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
</standard>
<server>
<NO>PASCAL 10-0491629 INIST</NO>
<ET>Fatigue in Parkinson's Disease: Prevalence and Associated Factors</ET>
<AU>BEISKE (Antoine G.); HAVARD LOGE (Jon); HJERMSTAD (Marianne J.); SVENSSON (Elisabeth)</AU>
<AF>Department of Neurology, Akershus University Hospital/Norvège (1 aut.); Department of Oncology, National Resource Centre for Late Effects, Oslo University Hospital Montebello/Norvège (2 aut.); Department of Behavioural Sciences in Medicine, University of Oslo/Norvège (2 aut.); Department of Oncology, Regional Centre for Excellence in Palliative Care, Oslo University Hospital/Ulleval/Norvège (3 aut.); Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology/Norvège (3 aut.); Department of Adult Mental Health, Division of Mental Health, Norwegian Institute of Public Health/Norvège (4 aut.)</AF>
<DT>Publication en série; Courte communication, note brève; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2010; Vol. 25; No. 14; Pp. 2456-2460; Bibl. 29 ref.</SO>
<LA>Anglais</LA>
<EA>The purpose of this study was to examine the prevalence of fatigue in Parkinson's disease (PD) patients and compare this to the general population. Factors associated with fatigue were investigated by linear regression. Fatigue was assessed by the fatigue questionnaire. The mean age of the 176 PD patients (41 % women) was 69 years (range 35-90), and the mean UPDRSIII was 22.3 (SD 11.7). Fatigue levels (means) were significantly higher in PD patients compared with the general population; however, effect sizes were moderate for women for physical and total fatigue indicating clinically significant differences here only. Only female PD patients had more chronic fatigue than the general population. Fatigue was related to characteristics of PD but also to sleep disturbance, depression, and gender. This population-based study demonstrates that fatigue is a common symptom in PD patients, but compared with the general population, clinically significant differences were only found for female PD patients.</EA>
<CC>002B17; 002B17G</CC>
<FD>Maladie de Parkinson; Syndrome de fatigue chronique; Pathologie du système nerveux; Fatigue; Prévalence; Norvège</FD>
<FG>Europe; Pathologie de l'encéphale; Syndrome extrapyramidal; Maladie dégénérative; Pathologie du système nerveux central</FG>
<ED>Parkinson disease; Chronic fatigue syndrome; Nervous system diseases; Fatigue; Prevalence; Norway</ED>
<EG>Europe; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease</EG>
<SD>Parkinson enfermedad; Fatiga crónica síndrome; Sistema nervioso patología; Fatiga; Prevalencia; Noruega</SD>
<LO>INIST-20953.354000192780100290</LO>
<ID>10-0491629</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000825 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000825 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:10-0491629
   |texte=   Fatigue in Parkinson's Disease: Prevalence and Associated Factors
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024